Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    November 2021
  1. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    PubMed     Abstract available


  2. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    PubMed     Abstract available


  3. AGARWAL R, Sinha AD, Cramer AE, Balmes-Fenwick M, et al
    Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2110730.
    PubMed     Abstract available


  4. TEITELBAUM I
    Peritoneal Dialysis.
    N Engl J Med. 2021;385:1786-1795.
    PubMed    


    October 2021
  5. MORELLE J, Marechal C, Yu Z, Debaix H, et al
    AQP1 Promoter Variant, Water Transport, and Outcomes in Peritoneal Dialysis.
    N Engl J Med. 2021;385:1570-1580.
    PubMed     Abstract available


  6. CHERTOW GM, Eckardt KU
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;385:e56.
    PubMed    


  7. BUNN HF
    Vadadustat for Anemia in Patients with Dialysis-Dependent or Non-Dialysis-Dependent Chronic Kidney Disease.
    N Engl J Med. 2021;385:e56.
    PubMed    


    August 2021
  8. HARIHARAN S, Israni AK, Danovitch G
    Long-Term Survival after Kidney Transplantation.
    N Engl J Med. 2021;385:729-743.
    PubMed    


    April 2021
  9. ECKARDT KU, Agarwal R, Aswad A, Awad A, et al
    Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021;384:1601-1612.
    PubMed     Abstract available


  10. CHERTOW GM, Pergola PE, Farag YMK, Agarwal R, et al
    Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
    N Engl J Med. 2021;384:1589-1600.
    PubMed     Abstract available


  11. LEVIN A
    Therapy for Anemia in Chronic Kidney Disease - New Interventions and New Questions.
    N Engl J Med. 2021;384:1657-1658.
    PubMed    


    March 2021
  12. LOOKSTEIN RA, Haruguchi H, Holden A
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. Reply.
    N Engl J Med. 2021;384:1173-1174.
    PubMed    


  13. PACKER D
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1173.
    PubMed    


  14. MAYUMI T, Okano H
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172-1173.
    PubMed    


  15. SWINNEN J
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1172.
    PubMed    


  16. DAVIDSON I
    Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas.
    N Engl J Med. 2021;384:1171-1172.
    PubMed    


  17. BAKRIS GL, Agarwal R, Filippatos G
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;384:e42.
    PubMed    


  18. MOURA-NETO JA, Ronco C
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  19. YOUNG MJ, Fuller PJ
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  20. EDWARDS NC, Ferro CJ, Townend JN
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  21. MAKEMBI AB, Mohamadou I, Galichon P
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


  22. BAUMSTEIN D
    Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2021;384:e42.
    PubMed    


    January 2021
  23. HEERSPINK HJL, Langkilde AM, Wheeler DC
    Dapagliflozin in Patients with Chronic Kidney Disease. Reply.
    N Engl J Med. 2021;384:389-390.
    PubMed    


  24. YASUDA H, Isobe S
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:389.
    PubMed    


  25. VOGT L
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2021;384:388-389.
    PubMed    


    December 2020
  26. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
    N Engl J Med. 2020;383:2219-2229.
    PubMed     Abstract available


    November 2020
  27. BHATT DL, Szarek M, Pitt B, Cannon CP, et al
    Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2020 Nov 16. doi: 10.1056/NEJMoa2030186.
    PubMed     Abstract available


    October 2020
  28. WALD R, Bagshaw SM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. Reply.
    N Engl J Med. 2020;383:1797-1798.
    PubMed    


  29. SU Y, Tu GW, Luo Z
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    PubMed    


  30. LUIJNENBURG TWF, Petjak M, de Pont AJM
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1797.
    PubMed    


  31. BOUCHARD J, Cutter G, Mehta R
    Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.
    N Engl J Med. 2020;383:1796.
    PubMed    


  32. CORTAZAR FB, Rhee EP, Gupta S, Sakhuja R, et al
    Case 34-2020: A 74-Year-Old Man with Chronic Kidney Disease.
    N Engl J Med. 2020;383:1768-1778.
    PubMed    


  33. INGELFINGER JR, Rosen CJ
    Finerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
    N Engl J Med. 2020 Oct 23. doi: 10.1056/NEJMe2031382.
    PubMed    


  34. FEIG DI
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1692.
    PubMed    


  35. BADVE SV, Pascoe EM
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1691-1692.
    PubMed    


  36. DORIA A, Galecki AT, Mauer M
    Allopurinol and Chronic Kidney Disease. Reply.
    N Engl J Med. 2020;383:1690-1691.
    PubMed    


  37. FERNANDEZ-PRADO R, Ortiz A, Perez-Gomez MV
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1690.
    PubMed    


  38. MCCORMICK N, Zhang Y, Choi HK
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689-1690.
    PubMed    


  39. CONWAY R
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1689.
    PubMed    


  40. PONTICELLI C, Podesta MA
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1688-1689.
    PubMed    


  41. KANG DH, Sanchez-Lozada LG, Johnson RJ
    Allopurinol and Chronic Kidney Disease.
    N Engl J Med. 2020;383:1687-1688.
    PubMed    


    September 2020
  42. HEERSPINK HJL, Stefansson BV, Correa-Rotter R, Chertow GM, et al
    Dapagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med. 2020 Sep 24. doi: 10.1056/NEJMoa2024816.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: